Literature DB >> 9466701

Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation.

A Bounacer1, R Wicker, M Schlumberger, A Sarasin, H G Suárez.   

Abstract

A high frequency (approximately 60%) of ret rearrangements in Chernobyl papillary thyroid carcinomas (PTC) has been reported recently. The data suggested that the radiation exposure may be a direct inducer of activating rearrangements in the ret gene. In our study, we have analyzed for the presence of RET/PTC oncogenes using the RT-PCR, XL-PCR, Southern blot and direct sequencing techniques, 39 human thyroid tumors from patients who had received external radiation for benign or malignant conditions. As controls, we studied 39 'spontaneous' tumors. Our results indicate that: 1) the overall frequency of ret rearrangements was 84% in papillary carcinomas (16/19) and 45% (9/20) in follicular adenomas; 2) in contrast with the results obtained in the Chernobyl tumors, the most frequently observed chimeric gene was RET/PTC1; and 3) all the tumors were negative for RET/PTC2. In the 'spontaneous' tumors, only the papillary carcinomas presented a ret rearrangement (15%: 3/20). Our data confirm the crucial role played by the ret proto-oncogene activating rearrangements in the development of radiation-associated thyroid tumors, and show, for the first time, the presence of RET/PTC genes in follicular adenomas appeared after external irradiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9466701     DOI: 10.1016/s0300-9084(97)82012-3

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

1.  RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations.

Authors:  Mosin S Khan; Qurteeba Qadri; Mudasir J Makhdoomi; Muneer A Wani; Aejaz A Malik; Madiha Niyaz; Shariq R Masoodi; Khurshid I Andrabi; Rauf Ahmad; Syed Mudassar
Journal:  Pathol Oncol Res       Date:  2018-11-22       Impact factor: 3.201

2.  ret/PTC activation is not associated with individual radiation dose estimates in a pilot study of neoplastic thyroid nodules arising in Russian children and adults exposed to Chernobyl fallout.

Authors:  R Michael Tuttle; Yvonne Lukes; Lynn Onstad; Eugeni Lushnikov; Alexander Abrosimov; Vladislav Troshin; Anatoli Tsyb; Scott Davis; Kenneth J Kopecky; Gary Francis
Journal:  Thyroid       Date:  2008-08       Impact factor: 6.568

Review 3.  Novel targets in non-small cell lung cancer: ROS1 and RET fusions.

Authors:  Justin F Gainor; Alice T Shaw
Journal:  Oncologist       Date:  2013-06-28

4.  Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.

Authors:  E Styring; J Seinen; M Dominguez-Valentin; H A Domanski; M Jönsson; F V von Steyern; H J Hoekstra; A J H Suurmeijer; M Nilbert
Journal:  Br J Cancer       Date:  2014-07-01       Impact factor: 7.640

5.  Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients.

Authors:  Kai Zhang; Huajun Chen; Ye Wang; Lin Yang; Chengzhi Zhou; Weiqiang Yin; Guangsuo Wang; Xinru Mao; Jianxing Xiang; Bing Li; Tengfei Zhang; Shihong Fei
Journal:  Oncol Res       Date:  2018-08-21       Impact factor: 5.574

6.  Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.

Authors:  Minke Shi; Weiran Wang; Jinku Zhang; Bobo Li; Dongxiao Lv; Danhua Wang; Sizhen Wang; Dezhi Cheng; Tonghui Ma
Journal:  Cancer Sci       Date:  2021-11-15       Impact factor: 6.716

Review 7.  [Research Progress of Fusion Genes RET in Non-small Cell Lung Cancer].

Authors:  Yujun Zheng; Wei Jiang; Dongyan Chen; Yanjun Li; Lulu Dai; Lei Huang; Mingji Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.